MULLENNIX STEPHEN (COO) sold 39.9% of their position (2.80K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $104.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/7/2019ACC: 0001209191-19-017932
-2.80K
Net shares
Net seller
$104.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.03K acquired · 9.84K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+7.03K
Price / share
—
Trade value
—
% of position
New position
2/14/2019
0.00→7.03K
Ordinary Shares
Direct
Shares
−2.80K
Price / share
$37.30
Trade value
$104.59K
% of position
39.9%
2/14/2019
7.03K→4.23K
Total
Net shares
+4.23K
Net value
-$104.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/14/2019 | M · Option Exercise | +7.03K | — | — | New position | 0.00 | 7.03K |
| Ordinary Shares Direct | 2/14/2019 | S · Sale | −2.80K | $37.30 | $104.59K | 39.9% | 7.03K | 4.23K |
| Total | +4.23K | -$104.59K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
7.03K shares
Shares
−7.03K
Strike price
Held after
14.07K
Exercisable
—
2/14/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares7.03K shares | 2/14/2019 | M · Option Exercise | −7.03K | — | 14.07K |